{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T04:58:08Z","timestamp":1744520288166},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00105-020-04679-z","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T13:02:46Z","timestamp":1599224566000},"page":"762-771","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Endokrine Mechanismen bei der\u00a0Pathophysiologie der Hidradenitis suppurativa"],"prefix":"10.1007","volume":"71","author":[{"given":"G.","family":"Nikolakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Karagiannidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G.","family":"Vaiopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"4679_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2165\/00002512-199405010-00006","volume":"5","author":"LB Barradell","year":"1994","unstructured":"Barradell\u00a0LB, Faulds\u00a0D (1994) Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer. Drugs Aging 5:59\u201380. https:\/\/doi.org\/10.2165\/00002512-199405010-00006","journal-title":"Drugs Aging"},{"key":"4679_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1365-2133.1996.tb07942.x","volume":"134","author":"JH Barth","year":"1996","unstructured":"Barth\u00a0JH, Layton\u00a0AM, Cunliffe\u00a0WJ (1996) Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol 134:1057\u20131059. https:\/\/doi.org\/10.1111\/j.1365-2133.1996.tb07942.x","journal-title":"Br J Dermatol"},{"key":"4679_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","volume":"164","author":"J Boer","year":"2011","unstructured":"Boer\u00a0J, Nazary\u00a0M (2011) Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a\u00a0misnomer? Br J Dermatol 164:170\u2013175. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.10071.x","journal-title":"Br J Dermatol"},{"key":"4679_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jaad.2017.08.042","volume":"78","author":"TL Bui","year":"2018","unstructured":"Bui\u00a0TL, Silva-Hirschberg\u00a0C, Torres\u00a0J, Armstrong\u00a0AW (2018) Hidradenitis suppurativa and diabetes mellitus: a systematic review and meta-analysis. J\u00a0Am Acad Dermatol 78:395\u2013402. https:\/\/doi.org\/10.1016\/j.jaad.2017.08.042","journal-title":"J Am Acad Dermatol"},{"key":"4679_CR5","first-page":"129","volume":"37","author":"MG Buimer","year":"2015","unstructured":"Buimer\u00a0MG, Wobbes\u00a0T, Klinkenbijl\u00a0JHG et\u00a0al (2015) Immunohistochemical analysis of steroid hormone receptors in hidradenitis suppurativa. Am J Surg 37:129\u2013132","journal-title":"Am J Surg"},{"key":"4679_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010186","author":"BC David","year":"2018","unstructured":"David\u00a0BC, Bragazzi\u00a0NL, Watad\u00a0A et\u00a0al (2018) Hidradenitis suppurativa associated with systemic lupus erythematosus: a case report. Medicine. https:\/\/doi.org\/10.1097\/MD.0000000000010186","journal-title":"Medicine"},{"key":"4679_CR7","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1111\/ced.13956","volume":"44","author":"RD Caposiena Caro","year":"2019","unstructured":"Caposiena Caro\u00a0RD, Bianchi\u00a0L (2019) Can retinoids flare hidradenitis suppurativa? A further case series. Clin Exp Dermatol 44:e153\u2013e154. https:\/\/doi.org\/10.1111\/ced.13956","journal-title":"Clin Exp Dermatol"},{"key":"4679_CR8","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1046\/j.1523-1747.2002.00613.x","volume":"119","author":"W Chen","year":"2002","unstructured":"Chen\u00a0W, Thiboutot\u00a0D, Zouboulis\u00a0CC (2002) Cutaneous androgen metabolism: basic research and clinical perspectives. J\u00a0Invest Dermatol 119:992\u20131007. https:\/\/doi.org\/10.1046\/j.1523-1747.2002.00613.x","journal-title":"J Invest Dermatol"},{"key":"4679_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3949\/ccjm.57.3.285","volume":"57","author":"DC Cumming","year":"1990","unstructured":"Cumming\u00a0DC (1990) Use of spironolactone in treatment of hirsutism. Cleve Clin J Med 57:285\u2013287. https:\/\/doi.org\/10.3949\/ccjm.57.3.285","journal-title":"Cleve Clin J Med"},{"key":"4679_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000339477","volume":"224","author":"C Dom\u00e9nech","year":"2012","unstructured":"Dom\u00e9nech\u00a0C, Matarredona\u00a0J, Escribano-Stabl\u00e9\u00a0JC et al (2012) Facial hidradenitis suppurativa in a\u00a028-year-old male responding to finasteride. Dermatology 224:307\u2013308. https:\/\/doi.org\/10.1159\/000339477","journal-title":"Dermatology"},{"key":"4679_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2133.1995.tb02663.x","volume":"133","author":"W Eicheler","year":"1995","unstructured":"Eicheler\u00a0W, Dreher\u00a0M, Hoffmann\u00a0R et al (1995) Immunohistochemical evidence for differential distribution of 5\u03b1-reductase isoenzymes in human skin. Br J Dermatol 133:371\u2013376. https:\/\/doi.org\/10.1111\/j.1365-2133.1995.tb02663.x","journal-title":"Br J Dermatol"},{"key":"4679_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/ced.13944","volume":"44","author":"CG Gallagher","year":"2019","unstructured":"Gallagher\u00a0CG, Kirthi\u00a0SK, Cotter\u00a0CC et\u00a0al (2019) Could isotretinoin flare hidradenitis suppurativa? A case series. Clin Exp Dermatol 44:777\u2013780. https:\/\/doi.org\/10.1111\/ced.13944","journal-title":"Clin Exp Dermatol"},{"key":"4679_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/J.JAAD.2018.06.063","volume":"80","author":"NM Golbari","year":"2019","unstructured":"Golbari\u00a0NM, Porter\u00a0ML, Kimball\u00a0AB (2019) Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa. J\u00a0Am Acad Dermatol 80:114\u2013119. https:\/\/doi.org\/10.1016\/J.JAAD.2018.06.063","journal-title":"J Am Acad Dermatol"},{"key":"4679_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","volume":"70","author":"DA Gold","year":"2014","unstructured":"Gold\u00a0DA, Reeder\u00a0VJ, Mahan\u00a0MG, Hamzavi\u00a0IH (2014) The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. J\u00a0Am Acad Dermatol 70:699\u2013703. https:\/\/doi.org\/10.1016\/j.jaad.2013.11.014","journal-title":"J Am Acad Dermatol"},{"key":"4679_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4161\/derm.19201","volume":"4","author":"M Haag","year":"2012","unstructured":"Haag\u00a0M, Hamann\u00a0T, Kulle\u00a0AE et\u00a0al (2012) Age and skin site related differences in steroid metabolism in male skin point to a\u00a0key role of sebocytes in cutaneous hormone metabolism. Dermatoendocrinol 4:58\u201364. https:\/\/doi.org\/10.4161\/derm.19201","journal-title":"Dermatoendocrinol"},{"key":"4679_CR16","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/bjs.1800721223","volume":"72","author":"BJ Harrison","year":"1985","unstructured":"Harrison\u00a0BJ, Kumar\u00a0S, Read\u00a0GF et\u00a0al (1985) Hidradenitis suppurativa: evidence for an endocrine abnormality. Br J Surg 72:1002\u20131004. https:\/\/doi.org\/10.1002\/bjs.1800721223","journal-title":"Br J Surg"},{"key":"4679_CR17","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/bjs.1800751011","volume":"75","author":"BJ Harrison","year":"1988","unstructured":"Harrison\u00a0BJ, Read\u00a0GF, Hughes\u00a0LE (1988) Endocrine basis for the clinical presentation of hidradenitis suppurativa. Br J Surg 75:972\u2013975. https:\/\/doi.org\/10.1002\/bjs.1800751011","journal-title":"Br J Surg"},{"key":"4679_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1365-2133.1988.tb03227.x","volume":"119","author":"GBE Jemec","year":"1988","unstructured":"Jemec\u00a0GBE (1988) The symptomatology of hidradenitis suppurativa in women. Br J Dermatol 119:345\u2013350. https:\/\/doi.org\/10.1111\/j.1365-2133.1988.tb03227.x","journal-title":"Br J Dermatol"},{"key":"4679_CR19","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1111\/ced.13953","volume":"44","author":"A-HR J\u00f8rgensen","year":"2019","unstructured":"J\u00f8rgensen\u00a0A\u2011HR, Thomsen\u00a0SF, Ring\u00a0HC (2019) Isotretinoin and hidradenitis suppurativa. Clin Exp Dermatol 44:e155\u2013e156. https:\/\/doi.org\/10.1111\/ced.13953","journal-title":"Clin Exp Dermatol"},{"key":"4679_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.1047","author":"AHR J\u00f8rgensen","year":"2020","unstructured":"J\u00f8rgensen\u00a0AHR, Aarestrup\u00a0J, Baker\u00a0JL, Thomsen\u00a0SF (2020) Association of birth weight, childhood body mass index, and height with risk of hidradenitis suppurativa. JAMA Dermatol. https:\/\/doi.org\/10.1001\/jamadermatol.2020.1047","journal-title":"JAMA Dermatol"},{"key":"4679_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/09546630510031403","volume":"16","author":"MA Joseph","year":"2005","unstructured":"Joseph\u00a0MA, Jayaseelan\u00a0E, Ganapathi\u00a0B, Stephen\u00a0J (2005) Hidradenitis suppurativa treated with finasteride. J\u00a0Dermatolog Treat 16:75\u201378. https:\/\/doi.org\/10.1080\/09546630510031403","journal-title":"J Dermatolog Treat"},{"key":"4679_CR22","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.surg.2005.06.053","volume":"138","author":"RJ Kagan","year":"2005","unstructured":"Kagan\u00a0RJ, Yakuboff\u00a0KP, Warner\u00a0P, Warden\u00a0GD (2005) Surgical treatment of hidradenitis suppurativa: a 10-year experience. Surgery 138:734\u2013741. https:\/\/doi.org\/10.1016\/j.surg.2005.06.053","journal-title":"Surgery"},{"key":"4679_CR23","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1365-2133.2011.10224.x","volume":"164","author":"S Kamp","year":"2011","unstructured":"Kamp\u00a0S, Fiehn\u00a0AM, Stenderup\u00a0K et\u00a0al (2011) Hidradenitis suppurativa: a\u00a0disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol 164:1017\u20131022. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10224.x","journal-title":"Br J Dermatol"},{"key":"4679_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11154-016-9366-z","volume":"17","author":"I Karagiannidis","year":"2016","unstructured":"Karagiannidis\u00a0I, Nikolakis\u00a0G, Sabat\u00a0R, Zouboulis\u00a0CC (2016) Hidradenitis suppurativa\/Acne inversa: an endocrine skin disorder? Rev Endocr Metab Disord 17:335\u2013341. https:\/\/doi.org\/10.1007\/s11154-016-9366-z","journal-title":"Rev Endocr Metab Disord"},{"key":"4679_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.det.2015.08.005","volume":"34","author":"I Karagiannidis","year":"2016","unstructured":"Karagiannidis\u00a0I, Nikolakis\u00a0G, Zouboulis\u00a0CC (2016) Endocrinologic aspects of hidradenitis suppurativa. Dermatol Clin 34:45\u201349. https:\/\/doi.org\/10.1016\/j.det.2015.08.005","journal-title":"Dermatol Clin"},{"key":"4679_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000473873","volume":"3075","author":"BN Khandalavala","year":"2017","unstructured":"Khandalavala\u00a0BN (2017) A disease-modifying approach for advanced hidradenitis suppurativa (regimen with Metformin, Liraglutide, Dapsone, and Finasteride): a case report. Case Rep Dermatol 3075:70\u201378. https:\/\/doi.org\/10.1159\/000473873","journal-title":"Case Rep Dermatol"},{"key":"4679_CR27","first-page":"44","volume":"9","author":"BN Khandalavala","year":"2016","unstructured":"Khandalavala\u00a0BN, Voutsalath\u00a0M (2016) Finasteride in hidradenitis suppurativa: A \u201cmale\u201d therapy for a\u00a0predominantly \u201cfemale\u201d disease. J\u00a0Clin Aesthet Dermatol 9:44\u201350","journal-title":"J Clin Aesthet Dermatol"},{"key":"4679_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/jdv.15940","volume":"34","author":"N Kirsten","year":"2020","unstructured":"Kirsten\u00a0N, Petersen\u00a0J, Hagenstr\u00f6m\u00a0K, Augustin\u00a0M (2020) Epidemiology of hidradenitis suppurativa in Germany \u2013 an observational cohort study based on a\u00a0multisource approach. J\u00a0Eur Acad Dermatol Venereol 34:174\u2013179. https:\/\/doi.org\/10.1111\/jdv.15940","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4679_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2310\/7750.2007.00019","volume":"11","author":"JN Kraft","year":"2007","unstructured":"Kraft\u00a0JN, Searles\u00a0GE (2007) Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy. J\u00a0Cutan Med Surg 11:125\u2013131. https:\/\/doi.org\/10.2310\/7750.2007.00019","journal-title":"J Cutan Med Surg"},{"key":"4679_CR30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2340\/00015555-1800","volume":"94","author":"CB Kromann","year":"2014","unstructured":"Kromann\u00a0CB, Ibler\u00a0KS, Kristiansen\u00a0VB, Jemec\u00a0GBE (2014) The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol 94:553\u2013557. https:\/\/doi.org\/10.2340\/00015555-1800","journal-title":"Acta Derm Venereol"},{"key":"4679_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712_1.x","volume":"17","author":"H Kurzen","year":"2008","unstructured":"Kurzen\u00a0H, Kurokawa\u00a0I, Jemec\u00a0GBE et\u00a0al (2008) What causes hidradenitis suppurativa? Exp Dermatol 17:455\u2013456. https:\/\/doi.org\/10.1111\/j.1600-0625.2008.00712_1.x","journal-title":"Exp Dermatol"},{"key":"4679_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/ajd.12362","volume":"56","author":"A Lee","year":"2015","unstructured":"Lee\u00a0A, Fischer\u00a0G (2015) A case series of 20 women with hidradenitis suppurativa treated with spironolactone. Australas J Dermatol 56:192\u2013196. https:\/\/doi.org\/10.1111\/ajd.12362","journal-title":"Australas J Dermatol"},{"key":"4679_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1993.tb03174.x","author":"F Lewis","year":"1993","unstructured":"Lewis\u00a0F, Messenger\u00a0AG, Wales\u00a0JKH (1993) Hidradenitis suppurativa as a\u00a0presenting feature of premature adrenarche. Br J Dermatol. https:\/\/doi.org\/10.1111\/j.1365-2133.1993.tb03174.x","journal-title":"Br J Dermatol"},{"key":"4679_CR34","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/ijd.14210","volume":"57","author":"CH Loo","year":"2018","unstructured":"Loo\u00a0CH, Tan\u00a0WC, Tang\u00a0JJ et\u00a0al (2018) The clinical, biochemical, and ultrasonographic characteristics of patients with hidradenitis suppurativa in Northern Peninsular Malaysia: a\u00a0multicenter study. Int J Dermatol 57:1454\u20131463. https:\/\/doi.org\/10.1111\/ijd.14210","journal-title":"Int J Dermatol"},{"key":"4679_CR35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/bjd.15904","volume":"178","author":"A Malara","year":"2018","unstructured":"Malara\u00a0A, Hughes\u00a0R, Jennings\u00a0L et\u00a0al (2018) Adipokines are dysregulated in patients with hidradenitis suppurativa. Br J Dermatol 178:792\u2013793. https:\/\/doi.org\/10.1111\/bjd.15904","journal-title":"Br J Dermatol"},{"key":"4679_CR36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/bjd.12884","volume":"171","author":"BA Matusiak","year":"2014","unstructured":"Matusiak\u00a0BA, Szepietowski\u00a0JC (2014) Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients. Br J Dermatol 171:170\u2013174. https:\/\/doi.org\/10.1111\/bjd.12884","journal-title":"Br J Dermatol"},{"key":"4679_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2165\/00003495-199957010-00014","volume":"57","author":"KJ McClellan","year":"1999","unstructured":"McClellan\u00a0KJ, Markham\u00a0A (1999) Finasteride. A review of its use in male pattern hair loss. Drugs 57:111\u2013126. https:\/\/doi.org\/10.2165\/00003495-199957010-00014","journal-title":"Drugs"},{"key":"4679_CR38","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40272-014-0091-3","volume":"16","author":"PR Mikkelsen","year":"2014","unstructured":"Mikkelsen\u00a0PR, Jemec\u00a0GBE (2014) Hidradenitis suppurativa in children and adolescents: a review of treatment options. Pediatr Drugs 16:483\u2013489. https:\/\/doi.org\/10.1007\/s40272-014-0091-3","journal-title":"Pediatr Drugs"},{"key":"4679_CR39","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","volume":"150","author":"IM Miller","year":"2014","unstructured":"Miller\u00a0IM, Ellervik\u00a0C, Vinding\u00a0GR et\u00a0al (2014) Association of metabolic syndrome and hidradenitis suppurativa. JAMA Dermatol 150:1273\u20131280. https:\/\/doi.org\/10.1001\/jamadermatol.2014.1165","journal-title":"JAMA Dermatol"},{"key":"4679_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2133.1986.tb05740.x","volume":"115","author":"PS Mortimer","year":"1986","unstructured":"Mortimer\u00a0PS, Dawber\u00a0RPR, Gales\u00a0MA, Moore\u00a0RA (1986) A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 115:263\u2013268. https:\/\/doi.org\/10.1111\/j.1365-2133.1986.tb05740.x","journal-title":"Br J Dermatol"},{"key":"4679_CR41","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/pde.13216","volume":"34","author":"F Mota","year":"2017","unstructured":"Mota\u00a0F, Machado\u00a0S, Selores\u00a0M (2017) Hidradenitis suppurativa in children treated with finasteride\u2014a case series. Pediatr Dermatol 34:578\u2013583. https:\/\/doi.org\/10.1111\/pde.13216","journal-title":"Pediatr Dermatol"},{"key":"4679_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/479354","author":"M Napolitano","year":"2015","unstructured":"Napolitano\u00a0M, Megna\u00a0M, Monfrecola\u00a0G (2015) Insulin resistance and skin diseases. Sci World\u00a0J. https:\/\/doi.org\/10.1155\/2015\/479354","journal-title":"Sci World J"},{"key":"4679_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0028-1093574","volume":"9","author":"F Neumann","year":"1977","unstructured":"Neumann\u00a0F (1977) Pharmacology and potential use of cyproterone acetate. Horm Metab Res 9:1\u201313. https:\/\/doi.org\/10.1055\/s-0028-1093574","journal-title":"Horm Metab Res"},{"key":"4679_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0029-1211261","volume":"102","author":"F Neumann","year":"1994","unstructured":"Neumann\u00a0F (1994) The antiandrogen cyproterone acetate: discovery, chemistry, basic pharmacology, clinical use and tool in basic research. Exp Clin Endocrinol 102:1\u201332. https:\/\/doi.org\/10.1055\/s-0029-1211261","journal-title":"Exp Clin Endocrinol"},{"key":"4679_CR45","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/0022-4731(86)90320-1","volume":"25","author":"F Neumann","year":"1986","unstructured":"Neumann\u00a0F, T\u00f6pert\u00a0M (1986) Pharmacology of antiandrogens. J\u00a0Steroid Biochem 25:885\u2013895","journal-title":"J Steroid Biochem"},{"key":"4679_CR46","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s40257-019-00442-w","volume":"20","author":"G Nikolakis","year":"2019","unstructured":"Nikolakis\u00a0G, Kyrgidis\u00a0A, Zouboulis\u00a0CC (2019) Is there a\u00a0role for antiandrogen therapy for hidradenitis suppurativa? A systematic review of published data. Am J Clin Dermatol 20:503\u2013513. https:\/\/doi.org\/10.1007\/s40257-019-00442-w","journal-title":"Am J Clin Dermatol"},{"key":"4679_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11154-016-9390-z","volume":"17","author":"G Nikolakis","year":"2017","unstructured":"Nikolakis\u00a0G, Stratakis\u00a0CA, Kanaki\u00a0T et\u00a0al (2017) Skin steroidogenesis in health and disease. Rev Endocr Metab Disord 17:247\u2013258. https:\/\/doi.org\/10.1007\/s11154-016-9390-z","journal-title":"Rev Endocr Metab Disord"},{"key":"4679_CR48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/jdv.15827","volume":"33","author":"A Offidani","year":"2019","unstructured":"Offidani\u00a0A, Molinelli\u00a0E, Sechi\u00a0A et\u00a0al (2019) Hidradenitis suppurativa in a\u00a0prepubertal case series: a\u00a0call for specific guidelines. J\u00a0Eur Acad Dermatol Venereol 33:28\u201331. https:\/\/doi.org\/10.1111\/jdv.15827","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4679_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000053267","volume":"54","author":"CE Orfanos","year":"2000","unstructured":"Orfanos\u00a0CE, Adler\u00a0YD, Zouboulis\u00a0CC (2000) The SAHA syndrome. Horm Res Paediatr 54:251\u2013258. https:\/\/doi.org\/10.1159\/000053267","journal-title":"Horm Res Paediatr"},{"key":"4679_CR50","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/ijd.14500","volume":"58","author":"K Phan","year":"2019","unstructured":"Phan\u00a0K, Charlton\u00a0O, Smith\u00a0SD (2019) Hidradenitis suppurativa and metabolic syndrome\u2014systematic review and adjusted meta-analysis. Int J Dermatol 58:1112\u20131117. https:\/\/doi.org\/10.1111\/ijd.14500","journal-title":"Int J Dermatol"},{"key":"4679_CR51","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1111\/ced.13922","volume":"44","author":"K Phan","year":"2019","unstructured":"Phan\u00a0K, Charlton\u00a0O, Smith\u00a0SD (2019) Hidradenitis suppurativa and diabetes mellitus: updated systematic review and adjusted meta-analysis. Clin Exp Dermatol 44:e126\u2013e132. https:\/\/doi.org\/10.1111\/ced.13922","journal-title":"Clin Exp Dermatol"},{"key":"4679_CR52","doi-asserted-by":"publisher","first-page":"650","DOI":"10.4103\/0019-5154.91821","volume":"56","author":"N Puri","year":"2011","unstructured":"Puri\u00a0N, Talwar\u00a0A (2011) A study on the management of hidradenitis suppurativa with retinoids and surgical excision. Indian J Dermatol 56:650\u2013651. https:\/\/doi.org\/10.4103\/0019-5154.91821","journal-title":"Indian J Dermatol"},{"key":"4679_CR53","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/jamadermatol.2013.2874","volume":"149","author":"HK Randhawa","year":"2013","unstructured":"Randhawa\u00a0HK, Hamilton\u00a0J, Pope\u00a0E (2013) Finasteride for the treatment of hidradenitis suppurativa in children and adolescents. JAMA Dermatol 149:732. https:\/\/doi.org\/10.1001\/jamadermatol.2013.2874","journal-title":"JAMA Dermatol"},{"key":"4679_CR54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbabio.2003.08.010","volume":"24","author":"PT Riis","year":"2016","unstructured":"Riis\u00a0PT, Ring\u00a0HC, Themstrup\u00a0L, Jemec\u00a0GB (2016) The role of androgens and estrogens in hidradenitis suppurativa\u2014a\u00a0systematic review. Acta Dermatovenerologica Croat 24:239\u2013249. https:\/\/doi.org\/10.1016\/j.bbabio.2003.08.010","journal-title":"Acta Dermatovenerologica Croat"},{"key":"4679_CR55","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0190-9622(99)80052-8","volume":"41","author":"JL Roberts","year":"1999","unstructured":"Roberts\u00a0JL, Fiedler\u00a0V, Imperato-McGinley\u00a0J et al (1999) Clinical dose ranging studies with finasteride, a\u00a0type 2 5\u03b1-reductase inhibitor, in men with male pattern hair loss. J\u00a0Am Acad Dermatol 41:555\u2013563. https:\/\/doi.org\/10.1016\/S0190-9622(99)80052-8","journal-title":"J Am Acad Dermatol"},{"key":"4679_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031810","author":"R Sabat","year":"2012","unstructured":"Sabat\u00a0R, Chanwangpong\u00a0A, Schneider-Burrus\u00a0S et al (2012) Increased prevalence of metabolic syndrome in patients with Acne inversa. Plos One. https:\/\/doi.org\/10.1371\/journal.pone.0031810","journal-title":"Plos One"},{"key":"4679_CR57","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s00105-013-2597-y","volume":"64","author":"CM Salavastru","year":"2013","unstructured":"Salavastru\u00a0CM, Fritz\u00a0K, Tiplica\u00a0GS (2013) Spironolacton in dermatologischen Behandlungen: \u201con-label-\u201d und Off-label-Indikationen. Hautarzt 64:762\u2013767. https:\/\/doi.org\/10.1007\/s00105-013-2597-y","journal-title":"Hautarzt"},{"issue":"2","key":"4679_CR58","first-page":"1","volume":"26","author":"S Saric-Bosanac","year":"2020","unstructured":"Saric-Bosanac S et al (2020) The role of hypothalamus-pituitary-adrenal (HPA)-like axis in inflammatory pilosebaceous disorders. Dermatol Online\u00a0J 26(2):1\u201313","journal-title":"Dermatol Online\u00a0J"},{"key":"4679_CR59","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2133.1986.tb05741.x","volume":"115","author":"RS Sawers","year":"1986","unstructured":"Sawers\u00a0RS, Randall\u00a0VA, Ebling\u00a0FJG (1986) Control of hidradenitis suppurativa in women using combined antiandrogen (Cyproterone-acetate) and estrogen therapy. Br J Dermatol 115:269\u2013274. https:\/\/doi.org\/10.1111\/j.1365-2133.1986.tb05741.x","journal-title":"Br J Dermatol"},{"key":"4679_CR60","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bjd.13777","volume":"173","author":"G Shalom","year":"2015","unstructured":"Shalom\u00a0G, Freud\u00a0T, Harman-Boehm\u00a0I et al (2015) Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients. Br J Dermatol 173:464\u2013470. https:\/\/doi.org\/10.1111\/bjd.13777","journal-title":"Br J Dermatol"},{"key":"4679_CR61","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1067\/mjd.2000.105557","volume":"43","author":"JC Shaw","year":"2000","unstructured":"Shaw\u00a0JC (2000) Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients. J\u00a0Am Acad Dermatol 43:498\u2013502. https:\/\/doi.org\/10.1067\/mjd.2000.105557","journal-title":"J Am Acad Dermatol"},{"key":"4679_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jsbmb.2013.02.006","volume":"137","author":"A Slominski","year":"2013","unstructured":"Slominski\u00a0A, Zbytek\u00a0B, Nikolakis\u00a0G et\u00a0al (2013) Steroidogenesis in the skin: Implications for local immune functions. J\u00a0Steroid Biochem Mol Biol 137:107\u2013123. https:\/\/doi.org\/10.1016\/j.jsbmb.2013.02.006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4679_CR63","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1046\/j.1523-1747.2003.12244.x","volume":"120","author":"D Thiboutot","year":"2003","unstructured":"Thiboutot\u00a0D, Jabara\u00a0S, McAllister\u00a0JM et al (2003) Human skin is a\u00a0steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J\u00a0Invest Dermatol 120:905\u2013914. https:\/\/doi.org\/10.1046\/j.1523-1747.2003.12244.x","journal-title":"J Invest Dermatol"},{"key":"4679_CR64","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1210\/jcem.84.4.5591","volume":"84","author":"S Venturoli","year":"1999","unstructured":"Venturoli\u00a0S, Marescalchi\u00a0O, Colombo\u00a0FM et al (1999) A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism. J\u00a0Clin Endocrinol Metab 84:1304\u20131310. https:\/\/doi.org\/10.1210\/jcem.84.4.5591","journal-title":"J Clin Endocrinol Metab"},{"key":"4679_CR65","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","volume":"27","author":"R Verdolini","year":"2013","unstructured":"Verdolini\u00a0R, Clayton\u00a0N, Smith\u00a0A et\u00a0al (2013) Metformin for the treatment of hidradenitis suppurativa: a little help along the way. J\u00a0Eur Acad Dermatol Venereol 27:1101\u20131108. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04668.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4679_CR66","first-page":"155","volume":"150","author":"R Verdolini","year":"2015","unstructured":"Verdolini\u00a0R et al (2015) Alitretinoin: a useful agent in the treatment of hidradenitis suppurativa, especially in women of child-bearing age. G\u00a0Ital Dermatol Venereol 150:155\u2013162","journal-title":"G Ital Dermatol Venereol"},{"key":"4679_CR67","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/jdv.14894","volume":"32","author":"I Vilanova","year":"2018","unstructured":"Vilanova\u00a0I, Hern\u00e1ndez\u00a0JL, Mata\u00a0C et\u00a0al (2018) Insulin resistance in hidradenitis suppurativa: a\u00a0case\u2013control study. J\u00a0Eur Acad Dermatol Venereol 32:820\u2013824. https:\/\/doi.org\/10.1111\/jdv.14894","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4679_CR68","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13003","author":"S Vural","year":"2019","unstructured":"Vural\u00a0S, G\u00fcndo\u011fdu\u00a0M, Akay\u00a0BN et\u00a0al (2019) Hidradenitis suppurativa: clinical characteristics and determinants of treatment efficacy. Dermatol Ther. https:\/\/doi.org\/10.1111\/dth.13003","journal-title":"Dermatol Ther"},{"key":"4679_CR69","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000363610","volume":"27","author":"R Werner","year":"2014","unstructured":"Werner\u00a0R, Holterhus\u00a0P (2014) Androgen action. Endocr Dev 27:28\u201340","journal-title":"Endocr Dev"},{"key":"4679_CR70","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1046\/j.1468-3083.2000.00087.x","volume":"14","author":"JM Von Der Werth","year":"2000","unstructured":"Von Der Werth\u00a0JM, Williams\u00a0HC (2000) The natural history of hidradenitis suppurativa. J\u00a0Eur Acad Dermatol Venereol 14:389\u2013392. https:\/\/doi.org\/10.1046\/j.1468-3083.2000.00087.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4679_CR71","first-page":"455","volume":"168","author":"E Wooltorton","year":"2003","unstructured":"Wooltorton\u00a0E (2003) Health and drug alerts: Diane-35 (cyproterone acetate): safety concerns. CMAJ 168:455","journal-title":"CMAJ"},{"key":"4679_CR72","first-page":"41","volume":"32","author":"P Yl\u00f6stalo","year":"1987","unstructured":"Yl\u00f6stalo\u00a0P, Heikkinen\u00a0J, Kauppila\u00a0A et al (1987) Low-dose spironolactone in the treatment of female hirsutism. Int J Fertil 32:41\u201345","journal-title":"Int J Fertil"},{"key":"4679_CR73","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00105-009-1894-y","volume":"61","author":"CC Zouboulis","year":"2010","unstructured":"Zouboulis\u00a0CC (2010) Die Talgdr\u00fcse. Hautarzt 61:467\u2013477. https:\/\/doi.org\/10.1007\/s00105-009-1894-y","journal-title":"Hautarzt"},{"key":"4679_CR74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jdv.15233","volume":"33","author":"CC Zouboulis","year":"2019","unstructured":"Zouboulis\u00a0CC, Bechara\u00a0FG, Dickinson-Blok\u00a0JL et al (2019) Hidradenitis suppurativa\/acne inversa: a\u00a0practical framework for treatment optimization\u2014systematic review and recommendations from the HS ALLIANCE working group. J\u00a0Eur Acad Dermatol Venereol 33:19\u201331. https:\/\/doi.org\/10.1111\/jdv.15233","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4679_CR75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2012.08006.x","author":"CC Zouboulis","year":"2012","unstructured":"Zouboulis\u00a0CC, Bechara\u00a0FG, Fritz\u00a0K et al (2012) S1-Leitlinie zur Therapie der Hidradenitis suppurativa\/acne inversa * (ICD-10 Ziffer: L73.2). JDDG. https:\/\/doi.org\/10.1111\/j.1610-0387.2012.08006.x","journal-title":"JDDG"},{"key":"4679_CR76","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1055\/s-2007-961807","volume":"39","author":"CC Zouboulis","year":"2007","unstructured":"Zouboulis\u00a0CC, Chen\u00a0WC, Thornton\u00a0MJ et\u00a0al (2007) Sexual hormones in human skin. Horm Metab Res 39:85\u201395. https:\/\/doi.org\/10.1055\/s-2007-961807","journal-title":"Horm Metab Res"},{"key":"4679_CR77","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"29","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis\u00a0CC, Desai\u00a0N, Emtestam\u00a0L et\u00a0al (2015) European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J\u00a0Eur Acad Dermatol Venereol 29:619\u2013644. https:\/\/doi.org\/10.1111\/jdv.12966","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4679_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16264","author":"CC Zouboulis","year":"2020","unstructured":"Zouboulis\u00a0CC, Nogueira da Costa\u00a0A, Fimmel\u00a0S, Zouboulis\u00a0KC (2020) Apocrine glands are bystanders in hidradenitis suppurativa and their involvement is gender specific. J\u00a0Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.16264","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4679_CR79","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/jdv.16147","volume":"34","author":"CC Zouboulis","year":"2020","unstructured":"Zouboulis\u00a0CC, Nogueira da Costa\u00a0A, Makrantonaki\u00a0E et\u00a0al (2020) Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. J\u00a0Eur Acad Dermatol Venereol 34:846\u2013861. https:\/\/doi.org\/10.1111\/jdv.16147","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4679_CR80","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1111\/j.1610-0387.2009.07171.x","volume":"8","author":"CC Zouboulis","year":"2010","unstructured":"Zouboulis\u00a0CC, Rabe\u00a0T (2010) Hormonelle Antiandrogene in der Aknetherapie. J\u00a0Dtsch Dermatol Ges 8:S60\u2013S74. https:\/\/doi.org\/10.1111\/j.1610-0387.2009.07171.x","journal-title":"J. Dtsch. Dermatol. Ges."}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04679-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-020-04679-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04679-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T01:19:19Z","timestamp":1630718359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-020-04679-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":80,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4679"],"URL":"https:\/\/doi.org\/10.1007\/s00105-020-04679-z","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"4 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"G.\u00a0Nikolakis, I.\u00a0Karagiannidis, A.G.\u00a0Vaiopoulos, M.\u00a0Becker und C.C.\u00a0Zouboulis. geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}